Corium to Join NASDAQ Biotechnology Index
December 12, 2017 07:30 ET
|
Corium International, Inc.
MENLO PARK, Calif., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Reports Fourth Quarter and Fiscal Year 2017 Financial Results and Corporate Highlights
November 16, 2017 16:02 ET
|
Corium International, Inc.
MENLO PARK, Calif., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Thursday, November 16, 2017
November 09, 2017 08:00 ET
|
Corium International, Inc.
MENLO PARK, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (NASDAQ:CORI) today announced that it will report financial results for the fourth quarter and fiscal year ended...
Corium to Present at Upcoming Healthcare Conferences
September 05, 2017 08:00 ET
|
Corium International, Inc.
MENLO PARK, Calif., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Reports Recent Corporate Highlights and Financial Results for Third Quarter Fiscal 2017
August 03, 2017 16:02 ET
|
Corium International, Inc.
MENLO PARK, Calif., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium to Report Third Quarter Fiscal 2017 Financial Results on Thursday, August 3, 2017
July 27, 2017 16:05 ET
|
Corium International, Inc.
MENLO PARK, Calif., July 27, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (NASDAQ:CORI) today announced that it will report financial results for the third quarter ended June 30, 2017...
Corium Presents Clinical Results from Pilot Bioequivalence Study of Corplex™ Donepezil Transdermal System at Alzheimer's Association International Conference® 2017
July 18, 2017 07:30 ET
|
Corium International, Inc.
MENLO PARK, Calif., July 18, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium to Present Clinical Results from Pilot Bioequivalence Study of Once-weekly Corplex™ Donepezil Transdermal System at Alzheimer's Association International Conference® 2017
July 06, 2017 08:30 ET
|
Corium International, Inc.
MENLO PARK, Calif., July 06, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Joins Russell 3000® Index
June 26, 2017 08:30 ET
|
Corium International, Inc.
MENLO PARK, Calif., June 26, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium to Present at the Jefferies 2017 Global Healthcare Conference
June 01, 2017 08:30 ET
|
Corium International, Inc.
MENLO PARK, Calif., June 01, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...